- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01035008
Confocal Endomicroscopy of Pancreatic InVivo
Detection of Neoplastic Pancreatic Cysts Using Probe Based Confocal Laser Endomicroscopy: A Prospective in Vivo Study
Confocal laser endomicroscopy (CLE) is a novel and highly promising imaging method for that allows in vivo imaging of the mucosal layer at resolution of approximately 1 micron. Cellular and sub-cellular structures as well as capillaries and single red blood cells can be visualized. CLE is now well established as a highly accurate method for distinguishing neoplasia in the gastrointestinal tract lumen via endoscopy. A major new breakthrough is the development of sub-millimeter CLE probes that can be passed via an image guided needle (nCLE) into solid organs and cysts.
It is hypothesized that nCLE will help distinguish the benign, premalignant and malignant cystic lesions of pancreas by visualizing the cellular lining of the cysts, thereby, avoiding unnecessary surgery in patient with benign cysts and guiding to early and effective surgical removal of high risk neoplastic lesions.
A prototype minimal risk nCLE system has been developed that can be passed via standard endoscopic ultrasound needles into the pancreas but FDA clearance for in vivo use is not expected until late 2010. The investigators propose to evaluate this prototype nCLE system in vivo during endoscopic ultrasound (EUS), as an initial pilot study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypothesis: the confocal laser endomicroscopy imaging of the nCLE can differentiate between non-mucinous, mucinous non- malignant and malignant pancreatic cysts in vivo and has increased sensitivity compared to endoscopic ultrasound-fine needle aspiration (EUS-FNA) tissue sampling. In this pilot study the investigators will primarily evaluate technical feasibility and interobserver agreement.
- In patients undergoing EUS for suspected pancreatic cysts, the investigators will evaluate the key nCLE image features of non mucinous, mucinous, and malignant pancreatic cystic neoplasms (PCN).
- The investigators will estimate the initial image quality, feasibility, and interobserver agreement of nCLE
- The investigators will establish the preliminary accuracy of nCLE to be used for planning a larger comparative trial
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing endoscopic ultrasound for evaluation of pancreatic cysts (including pseudocysts and suspected pancreatic cystic neoplasms) in the gastrointestinal (GI) lab at Mayo Clinic Jacksonville.
Exclusion Criteria:
- Unwilling/unable to consent;
- Solid pancreatic mass on computerized axial tomography/magnetic resonance (CT/MR);
- Allergy to Fluorescein;
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Diagnostic
The investigators are testing a new method called confocal laser endomicroscopy to see if it can detect pre-cancerous abnormalities in the lining of the cysts found in your pancreas.
This will involve using a very thin fiber-shaped microscope which will be passed through a needle during the EUS procedure.
|
The investigators will do the standard EUS procedure.
If a cyst is seen in the pancreas during EUS, the investigators will administer a special dye called fluorescein through the IV, and then use the new fiber-shaped microscope to take pictures of the lining of the cysts.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Differentiate between non-mucinous, mucinous non-malignant & malignant pancreatic cysts in vivo
Time Frame: One day (completion of the EUS)
|
One day (completion of the EUS)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael B. Wallace, MD, Mayo Clinic
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-006345
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Cysts
-
Mayo ClinicCompleted
-
University of ChicagoMayo Clinic; Yale University; University of Washington; University of California... and other collaboratorsCompletedPancreatic CystsUnited States
-
University of OklahomaTerminated
-
Milton S. Hershey Medical CenterCompletedMucinous Pancreatic CystsUnited States
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Massachusetts General HospitalTerminatedPancreatic Cysts
-
Kaiser PermanenteCompletedPancreatic CystsUnited States
-
Indiana UniversityCompleted
-
University of California, IrvineCompleted
-
University of FloridaCompletedPancreatic PseudocystsUnited States
Clinical Trials on Endoscopic Ultrasound (EUS)
-
Tanta UniversityUnknownEsophageal Diseases | Pancreatic Diseases | Gastric Disease | Intestinal DiseaseEgypt
-
Fondazione del Piemonte per l'OncologiaRecruitingSubepithelial Gastrointestinal TumorsItaly
-
University of FloridaJohns Hopkins University; Mayo Clinic; Yale University; Columbia University; Ochsner... and other collaboratorsCompletedGastroenterology | LesionsUnited States
-
Methodist Health SystemEnrolling by invitation
-
University of FloridaTerminatedCancerUnited States
-
Hunter Holmes Mcguire Veteran Affairs Medical CenterUnknownEsophageal AdenocarcinomaUnited States
-
Changhai HospitalRecruitingDiagnoses DiseaseChina
-
Carol Davila University of Medicine and PharmacyInstitutul Clinic Fundeni; Bucharest Emergency HospitalUnknownPancreatic AdenocarcinomaRomania
-
Texas Tech University Health Sciences Center, El...CompletedPancreatic or Peripancreatic Lesions | Lesions in the Esophagus, Stomach, Duodenum or Rectum | Mediastinal ( Chest) Masses | Enlarged Lymph NodesUnited States
-
Texas Tech University Health Sciences Center, El...CompletedDiabetic Gastroparesis | Idiopathic GastroparesisUnited States